Patents by Inventor Yuangqing Tang

Yuangqing Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND CAPABLE OF REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH, AND PREPARATION METHOD THEREFOR
    Publication number: 20250250283
    Abstract: Disclosed are a compound of formula (I) capable of regulating and controlling the activity of 15-PGDH, or a stereoisomer thereof, a tautomer thereof or a mixture thereof, or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a prodrug thereof, a pharmaceutical composition comprising the same, and use of the compound in the preparation of a 15-PGDH inhibitor.
    Type: Application
    Filed: April 13, 2023
    Publication date: August 7, 2025
    Inventors: Sen JI, Hao WANG, Wenqing ZHANG, Jie LIANG, Xiao WANG, Lin TIAN, Ze FENG, Nan LI, Yuangqing TANG, Jing WANG, Xiaodong ZHANG, Jun TANG
  • Spiro and dispiro 1,2,4-trioxolane antimalarials
    Patent number: 6906205
    Abstract: A means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane is described. The preferred 1,2,4-trioxolanes include a spiroadamantane group on one side of the trioxolane group, and a spirocyclohexyl on the other side of the trioxolane group, whereby the spirocyclohexyl ring is preferably substituted at the 4-position. In comparison to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: June 14, 2005
    Assignee: Medicines for Malaria Venture MMV
    Inventors: Jonathan L. Vennerstrom, Yuxiang Dong, Jacques Chollet, Hugues Matile, Maniyan Padmanilayam, Yuangqing Tang, William N. Charman
  • Spiro and dispiro 1,2,4-trioxolane antimalarials
    Publication number: 20040186168
    Abstract: A means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane is described. The preferred 1,2,4-trioxolanes include a spiroadamantane group on one side of the trioxolane group, and a spirocyclohexyl on the other side of the trioxolane group, whereby the spirocyclohexyl ring is preferably substituted at the 4-position. In comparison to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.
    Type: Application
    Filed: December 19, 2003
    Publication date: September 23, 2004
    Applicant: MEDICINES FOR MALARIA VENTURE MMV
    Inventors: Jonathan L. Vennerstrom, Yuxiang Dong, Jacques Chollet, Hugues Matile, Maniyan Padmanilayam, Yuangqing Tang, William N. Charman